DR. OSAMA N EL-ASSAL, MBBCH ( MD)
Medical Practice at Childrens Dr, Columbus, OH
License number
Ohio 57013770
Category
Medical Practice
Type
Pediatrics
Address
Address
700 Childrens Dr, Columbus, OH 43205
Phone
(614) 722-2000
Professional information
Osama N El-Assal, Akron OH
Specialties:
Pediatric Emergency Medicine
Address:
1 Perkins Sq, Akron 44308
(330) 543-3000 (Phone)
700 Childrens Dr, Columbus 43205
(614) 722-2000 (Phone)
CHILDRENS HOSPITAL MEDICAL CENTER OF AKRON
1 Perkins Sq, Akron 44308
(330) 543-1000 (Phone), (330) 543-3220 (Fax)
CHILDRENS HOSPITAL MEDICAL CENTER OF AKRON
1 Perkins Sq, Akron 44308
(330) 543-1000 (Phone), (330) 543-3302 (Fax)
(330) 543-3000 (Phone)
700 Childrens Dr, Columbus 43205
(614) 722-2000 (Phone)
CHILDRENS HOSPITAL MEDICAL CENTER OF AKRON
1 Perkins Sq, Akron 44308
(330) 543-1000 (Phone), (330) 543-3220 (Fax)
CHILDRENS HOSPITAL MEDICAL CENTER OF AKRON
1 Perkins Sq, Akron 44308
(330) 543-1000 (Phone), (330) 543-3302 (Fax)
Certifications:
Pediatric Emergency Medicine, 2013, Pediatrics, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Osama N El-Assal, Columbus OH
Specialties:
Pediatrician
Address:
700 Childrens Dr, Columbus, OH 43205
Heparin Binding Epidermal Growth Factor (Hb-Egf) For Use In Methods Of Treating And Preventing Intestinal Injury Related To Hemorrhagic Shock And Resuscitation
US Patent:
2013016, Jun 27, 2013
Filed:
Jan 9, 2012
Appl. No.:
13/346285
Inventors:
Gail E. Besner - Dublin OH, US
Osama N. El-Assal - Gahanna OH, US
Osama N. El-Assal - Gahanna OH, US
Assignee:
NATIONWIDE CHILDREN'S HOSPITAL INC. - Columbus OH
International Classification:
A61K 38/18
US Classification:
514 96
Abstract:
The invention is related to methods of protecting, preventing and reducing intestinal injury in a human subject suffering from or at risk for shock, hemorrhagic shock or hemorrhagic shock and resuscitation (HS/R) comprising administering heparin binding epidermal growth factor (HB-EGF). The invention is also related to methods of inhibiting deterioration of intestinal blood flow and methods of preserving and increasing intestinal blood flow by administering HB-EGF to a human subject. In addition, the methods of the invention should improve the clinical outcome of human subject suffering from or at risk for shock, hemorrhagic shock or hemorrhagic shock and resuscitation.
Heparin Binding Epidermal Growth Factor (Hb-Egf) For Use In Methods Of Treating And Preventing Intestinal Injury Related To Hemorrhagic Shock And Resuscitation
US Patent:
2010022, Sep 2, 2010
Filed:
Apr 28, 2008
Appl. No.:
12/598082
Inventors:
Gail E. Besner - Dublin OH, US
Osama N. El-Assal - Gahanna OH, US
Osama N. El-Assal - Gahanna OH, US
Assignee:
NATIONWIDE CHILDREN'S HOSPITAL - Columbus OH
International Classification:
A61K 38/18, A61P 9/00
US Classification:
514 12
Abstract:
The invention is related to methods of protecting, preventing and reducing intestinal injury in a human subject suffering from or at risk for shock, hemorrhagic shock or hemorrhagic shock and resuscitation (HS/R) comprising administering heparin binding epidermal growth factor (HB-EGF). The invention is also related to methods of inhibiting deterioration of intestinal blood flow and methods of preserving and increasing intestinal blood flow by administering HB-EGF to a human subject. In addition, the methods of the invention should improve the clinical outcome of human subject suffering from or at risk for shock, hemorrhagic shock or hemorrhagic shock and resuscitation.